115 related articles for article (PubMed ID: 20132205)
1. CD4+/CD56+ TdT+ haematodermic neoplasm (previously called blastic natural killer cell lymphoma) in a patient with chronic human T-cell leukaemia virus type 1 infection: a previously unreported association.
Gurgen J; Hogan D; Muller K; Flowers J; Sexton W
Br J Dermatol; 2010 Jun; 162(6):1395-7. PubMed ID: 20132205
[No Abstract] [Full Text] [Related]
2. CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
Hamadani M; Magro CM; Porcu P
Br J Haematol; 2008 Jan; 140(2):122. PubMed ID: 17991297
[No Abstract] [Full Text] [Related]
3. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier.
Ohmatsu H; Sugaya M; Fujita H; Miyagaki T; Kadono T; Maeda D; Takazawa Y; Fukayama M; Tamaki K; Sato S
Acta Derm Venereol; 2010 May; 90(3):324-5. PubMed ID: 20526566
[No Abstract] [Full Text] [Related]
5. CD4+/CD56+ hematodermic neoplasm: blastic NK cell lymphoma in a 6-year-old child: report of a case and review of literature.
Eguaras AV; Lo RW; Veloso JD; Tan VG; Enriquez ML; Del Rosario ML
J Pediatr Hematol Oncol; 2007 Nov; 29(11):766-9. PubMed ID: 17984695
[TBL] [Abstract][Full Text] [Related]
6. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
7. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
Zhang K; Prichard JW; Brown RE
Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
[TBL] [Abstract][Full Text] [Related]
8. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
Herling M; Jones D
Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
[TBL] [Abstract][Full Text] [Related]
9. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
11. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
[TBL] [Abstract][Full Text] [Related]
12. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell lymphotropic virus-1-positive T-cell leukemia/lymphoma in a child. Report of a case and review of the literature.
Lin BT; Musset M; Székely AM; Alexandre J; Fraitag S; Bodemer C; Charpentier A; Frenoy N; Misset JL; Medeiros LJ; Rappaport H
Arch Pathol Lab Med; 1997 Dec; 121(12):1282-6. PubMed ID: 9431320
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
15. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
16. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
[TBL] [Abstract][Full Text] [Related]
17. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
[TBL] [Abstract][Full Text] [Related]
18. CD56-negative blastic natural killer-cell lymphoma (agranular CD4(+)/CD56(+) haematodermic neoplasm)?
Kawai K
Br J Dermatol; 2005 Feb; 152(2):369-70. PubMed ID: 15727657
[No Abstract] [Full Text] [Related]
19. Adult T-cell leukemia/lymphoma in an adolescent presenting with skin lesions.
Lucas CT; Gillis KJ; Ness JM; Hammers YA; Crawford DF; Kelly DR; Theos A
Pediatr Dermatol; 2008; 25(3):373-7. PubMed ID: 18577047
[TBL] [Abstract][Full Text] [Related]
20. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]